Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12
Policy
Policy | 12 March 2022

Govt earmarks Rs 500 crore for pharma clusters and MSMEs

Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme

Policy
Policy | 27 February 2022

Cabinet approves Ayushman Bharat Digital Mission at an outlay of Rs 1,600 cr.

Citizens will be able to create their ABHA (Ayushman Bharat Health Account) numbers, to which their digital health records can be linked

Policy
Policy | 27 February 2022

Industry seeks favourable policy for India to move up the pharma value chain globally

N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry

Policy
Policy | 25 February 2022

Mandaviya launches ICMR/ DHR policy on biomedical innovation & entrepreneurship

This policy will ensure multi-disciplinary collaboration, promote start-up culture and develop an innovation-led ecosystem at medical institutes across the country

Policy
Policy | 21 February 2022

Gujarat unveils ambitious Biotech Policy 2022-27

According to the state government, it will also provide support to special projects such as preclinical testing, genome sequencing in the private sector, private sector BSL-3 lab-vaccine development and manufacturing and testing and certification laboratories

Policy
Policy | 26 January 2022

Mandaviya reviews public health preparedness to Covid-19

Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation

Policy
Policy | 08 December 2021

NMPB and CSIR-CIMAP sign MoU for joint collaboration

Working under the Ministry of Ayush, NMPB is mandated to coordinate all matters relating to medicinal plants and support policies and programs for growth of trade, export, conservation, and cultivation of medicinal plants

Policy
Policy | 03 December 2021

Over one lakh SARS-CoV-2 genomes sequenced till November

Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry

Policy
Policy | 30 November 2021

Govt reviews public health preparedness with states/UTs over Omicron

The Omicron variant doesn't escape RTPCR and RAT; States advised to ramp up testing for prompt and early identification of any cases

Policy
Policy | 16 November 2021

Indian Pharmacopoeia Commission revises and adds new impurities and IP reference standards

The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards

Policy
Policy | 01 November 2021

EMA encourages companies to submit type I variations by end- November

Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021

Policy
Policy | 27 October 2021

PLI scheme has the potential to make India a pharma hub: Dr Mandaviya

FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year

Policy
Policy | 26 October 2021

NPPA fixes ceiling price for anti-diabetic generic medicines

A total of 12 generic medicines have been included in the list

Policy
Policy | 25 October 2021

India ramps up medical education with substantial investments

A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014

Policy
Policy | 16 October 2021

Govt. removes export curbs on Covid-19 kits

The export policy of all diagnostic kits and reagents (including instruments /apparatus) ... is being made free with immediate effect," the directorate general of foreign trade (DGFT) said in a notification

Policy
Policy | 09 October 2021

ASU drug manufacturing licence goes online

The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence

Policy
Policy | 21 September 2021

AYUSH minister Sonowal exhorts researchers to explore Indian traditional medicine

Assam is home to more than 1,700 species of medicinal plants

Policy
Policy | 20 September 2021

India to resume export of Covid-19 vaccines from October

The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month

Policy
Policy | 15 September 2021

Jharkhand to set up pharma park

The pharma park will be built at an estimated cost of Rs 34.94 crore and will be spread over 50 acres at Chanho close to Ranchi

Policy
Policy | 09 September 2021

New law to regulate drugs and medical devices soon

The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry

Startup

Digitization